• Corpus ID: 21005008

Drug-induced Oral Candidiasis : A Case Report

  title={Drug-induced Oral Candidiasis : A Case Report},
  author={A. Patil and H. R. Susmitha and S. Basappa and M. Mahesh},
Archana Patil1, H R Susmitha2, Srisha Basappa3, M S Mahesh4 1Senior Lecturer, Department of Oral Medicine and Radiology, Farooqia Dental College and Hospital, Mysuru, Karnataka, India, 2Post-graduate, Department of Oral Medicine and Radiology, Farooqia Dental College and Hospital, Mysuru, Karnataka, India, 3Head and Professor, Department of Oral Medicine and Radiology, Farooqia Dental College and Hospital, Mysuru, Karnataka, India, 4Reader, Department of Oral Medicine and Radiology, Farooqia… 

Figures from this paper

Ampicillin Induced Oral Candidiasis: A Case Report
The following case presents an evidence that ampicillin in therapeutic dose can be associated with oral thrush.
Diagnosis and Management of Pseudomembranous Candidiasis
Oral candidiasis is one of the most common, treatable oral mucosal infections seen in persons with human immunodeficiency virus (HIV) infection or acquired immune deficiency syndrome (AIDS), and can be a frequent and significant source of oral discomfort, pain, loss of taste, and aversion to food.


Oral candidosis and the therapeutic use of antifungal agents in dentistry.
Proposed classification for the presentation of oral candidosis is outlined as are examples of these topical infections, such as erythematous, pseudomembranous and hyperplastic candidosis, as well as angular chelitis and median rhomboid glossitis.
Oral candidiasis
Oral candidiasis is a common opportunistic infection of the oral cavity caused by an overgrowth of Candida species, the commonest being Candida albicans. The incidence varies depending on age and
[Infections of the oral mucosa].
The most common infections of the oral mucosa are those caused by Candida albicans and herpes simplex virus, and treatment most importantly includes elimination of any predisposing factors such as smoking, sub-optimal denture hygiene and hyposalivation.
Candidiasis and dysphonia complicating beclomethasone treatment of asthma.
Although dysphonia and thrush were both related to beclomethasone usage, they did not appear to be directly related to one another, and they required different treatments (voice rest and nystatin), they need not preclude the long-term use of beclometrichasone, even in high dosage when required.
Pathogenesis and treatment of oral candidosis
The aim of this review is to give the reader a contemporary overview of oral candidosis, the organisms involved, and the management strategies that are currently employed or could be utilised in the future.
Oral medicine and pathology : a guide to diagnosis and management
The history of dental caries, anomalies of Teeth, and the role of tobacco use Prevention and Cessation in this disease have been studied.
Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber.
It is concluded that beclomethasone delivered by MDI plus Aerochamber is more efficacious in reducing oral prednisone dependency and produces less Candida infection and colonization than beClomethas one delivered byMDI alone.
Salivary IgA and Oral Candidiasis in Asthmatic Patients Treated with Inhaled Corticosteroid
The results suggest that inhaled corticosteroids can potentially decrease salivary total IgA but that host factors are also important in the development of oral candidiasis.
Challenges in the Management of Bronchial Asthma Among Adults in Nigeria: A Systematic Review
Challenges in asthma management were found during diagnosis, treatment, and follow-up, and there are wide variations in diagnostic criteria for bronchial asthma and lack of standard diagnostic equipment leading to under or misdiagnosis.
Inhaled Corticosteroids and the Occurrence of Oral Candidiasis: A Prescription Sequence Symmetry Analysis
This study found a significant and clinically relevant increased number of patients receiving medication for oral candidiasis in the first year after therapy initiation with ICS, but remains increased up to at least 1 year after ICS initiation.